1. Anlotinib Combined with S-1 in Third- or Later-Line Stage IV Non-Small Cell Lung Cancer Treatment: A Phase II Clinical Trial. (13th September 2021) Authors: Xiang, Miao; Yang, Xiyue; Ren, Surong; Du, Huan; Geng, Lidan; Yuan, Li; Wen, Yixue; Lin, Binwei; Li, Jie; Zhang, Yu; Feng, Gang; Du, Xiaobo Journal: Oncologist Issue: Volume 26:Number 12(2021) Page Start: e2130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anlotinib Combined with S‐1 in Third‐ or Later‐Line Stage IV Non‐Small Cell Lung Cancer Treatment: A Phase II Clinical Trial. (13th September 2021) Authors: Xiang, Miao; Yang, Xiyue; Ren, Surong; Du, Huan; Geng, Lidan; Yuan, Li; Wen, Yixue; Lin, Binwei; Li, Jie; Zhang, Yu; Feng, Gang; Du, Xiaobo Journal: Oncologist Issue: Volume 26:Number 12(2021) Page Start: e2130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays. (January 2022) Authors: Gao, Feng; Yang, Yiwei; Zhu, Hongyu; Wang, Jianxin; Xiao, Dexin; Zhou, Zheng; Dai, Tangzhi; Zhang, Yu; Feng, Gang; Li, Jie; Lin, Binwei; Xie, Gang; Ke, Qi; Zhou, Kui; Li, Peng; Shen, Xuming; Wang, Hanbin; Yan, Longgang; Lao, Chenglong; Shan, Lijun Journal: Radiotherapy and oncology Issue: Volume 166(2022) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. Issue 3 (22nd January 2021) Authors: Yang, Xiyue; Wang, Lei; Du, Huan; Lin, Binwei; Yi, Jie; Wen, Xuemei; Geng, Lidan; Du, Xiaobo Other Names: Chatterjee. Sampurna section editor. Journal: Medicine Issue: Volume 100:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗